Preventing Amyloid-related Diseases Comprising 4-o-methylhonokol

Stix, Gary "Alzheimer's: Forestalling the Darkness”. Scientific American, Jun. 2010, pp. 51-57.* Tada et al. “Intestinal pseudo-obstruction in patients with amyliodosis: clinicopathologic differences between chemical types of amyloid protein' Gut, 1993, vol. 34, pp. 1412-1417.* Sam Gandy, “The role of cerebal amyloid B. Accumulation in com mon forms of Alzheimer disease.” The Journal of Clinical Investiga tion, vol. 115, No. 5, May 2005, pp. 1121-1129. Laura Gasparini. “Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.” Brain Research Reviews, vol. 48, 2005, pp. 400-408. Crystal Pallister et al., “Lymphocyte Content of Amyloid Precursor Protein is Increased in Down's Syndrome and Aging.” Neurobiology of Aging, vol. 18. No. 1, 1997, pp. 97-103. Yasuhiro Arai et al., “Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains.” Brain & Development, vol. 19, 1997, pp. 290-294. James K. Nitao et al., “Bioactive Neolignans from the leaves of Magnolia virginiana.” Phytochemistry, vol. 30, No. 7, 1991, pp. 2193-21.95. David H. Small, “Mechanisms of Synaptic Homeostasis in Alzheimer's Disease. Current Alzheimer Research, vol. 1, No. 1, 2004, pp. 27-32. Yoshiyasu Fukuyama et al., “Neurotrophic Sesquiterpene Neolignans from Magnolia obovata: Structure and Neurotrophic Activity.” Tetrahedron, vol. 48, No. 3, 1992, pp. 377–392. Shoji Yahara et al., “Isolation and Characterization of Phenolic Com pounds from Magnoliae Cortex Produced in China.” Chem. Pharm. Bull, vol.39, No. 8, 1991, pp. 2024-2036. Concetta M. Forchetti, "Treating Patients With Moderate to Severe Alzheimer's Disease: Implications of Recent Pharmacologic Stud ies.” Prim Care CompanionJ Clin Psychiatry vol. 7, No. 4, 2005, pp. 155-161. F.S. El-Ferally et al., “Isolation and Characterization of Magnolol. Honokiol and Honokiol Monomethyl Ether from Magnolia grandiflora L. Seeds.” Lloydia, 1978, 653. Xiongwei Zhu et al., “Oxidative stress signalling in Alzheimer's disease.” Brain Research, vol. 1000, 2004, pp. 32-39.